These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35256916)

  • 1. Development and validation of a multi-parameter nomogram for predicting prostate cancer: a retrospective analysis from Handan Central Hospital in China.
    Nan L; Guo K; Li M; Wu Q; Huo S
    PeerJ; 2022; 10():e12912. PubMed ID: 35256916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
    Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
    BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.
    Chen S; Yang Y; Peng T; Yu X; Deng H; Guo Z
    Int J Med Sci; 2020; 17(10):1366-1374. PubMed ID: 32624693
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.
    Lughezzani G; Lazzeri M; Haese A; McNicholas T; de la Taille A; Buffi NM; Fossati N; Lista G; Larcher A; Abrate A; Mistretta A; Bini V; Palou Redorta J; Graefen M; Guazzoni G
    Eur Urol; 2014 Nov; 66(5):906-12. PubMed ID: 24361258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
    Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the diagnostic capacity of PSAMR combined with PI-RADS scoring for clinically significant prostate cancer and establishment and validation of the Nomogram prediction model.
    Li D; Zhang L; Xu Y; Wu X; Hua S; Jiang Y; Huang Q; Gao Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11309-11317. PubMed ID: 37365430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.
    Nomura M; Ito K; Miyakubo M; Sekine Y; Tamura Y; Shimizu N; Aoki S; Suzuki K
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):202-9. PubMed ID: 22143446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
    Hansen J; Auprich M; Ahyai SA; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Fisch M; Abbou CC; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Pummer K; Graefen M; Haese A; Walz J; Briganti A; Shariat SF; Chun FK
    Eur Urol; 2013 Feb; 63(2):201-9. PubMed ID: 22854248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are prostate biopsies necessary for all patients 75years and older?
    Chen Y; Fan Y; Yang Y; Jin J; Zhou L; He Z; Zhao Z; He Q; Wang X; Yu W; Wu S
    J Geriatr Oncol; 2018 Mar; 9(2):124-129. PubMed ID: 28939384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a Chinese nomogram based on muti-parametric magnetic resonance for predicting the probability of prostate cancer in patients after initial negative biopsy].
    Huang C; Ji GJ; Song G; Wang H; Chen YK; Zhou LQ
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):132-135. PubMed ID: 29343039
    [No Abstract]   [Full Text] [Related]  

  • 13. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.
    Tang P; Chen H; Uhlman M; Lin YR; Deng XR; Wang B; Yang WJ; Xie KJ
    Asian J Androl; 2013 Jan; 15(1):129-33. PubMed ID: 23291910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a prostate health index-based nomogram for predicting prostate cancer.
    Zhu Y; Han CT; Zhang GM; Liu F; Ding Q; Xu JF; Vidal AC; Freedland SJ; Ng CF; Ye DW
    Sci Rep; 2015 Oct; 5():15341. PubMed ID: 26471350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From Prostate Cancer.
    Liu Y; Li L; Jiang D; Yang M; Gao X; Lv K; Xu W; Wei H; Wan W; Xiao J
    Spine (Phila Pa 1976); 2021 Mar; 46(6):E364-E373. PubMed ID: 33620180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
    Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
    Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy.
    Wu Q; Li F; Yin X; Gao J; Zhang X
    Medicine (Baltimore); 2021 Dec; 100(50):e28196. PubMed ID: 34918677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer.
    Xie W; Xu Z; Qiu Y; Ye W; Zhang Z; Wang C; Zang J
    Biomed Res Int; 2023; 2023():9936087. PubMed ID: 36685670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction.
    Oliveira M; Marques V; Carvalho AP; Santos A
    BJU Int; 2011 Jun; 107(11):1780-3. PubMed ID: 20883487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.